COVID-19 vaccine advice
ANZCA President Dr Vanessa Beavis has had further discussions about the COVID-19 vaccination roll-out regarding concerns with the AstraZeneca vaccine.
Find out more
STP stakeholder forum a success
35 delegates attended our virtual Specialist Training Program (STP) stakeholder forum on 10 June.
Find out more
New university role for ANZCA councillor Professor David Story
ANZCA's Safety and Quality Chair Professor David Story has been appointed the inaugural Head of the Department of Critical Care in the University of Melbourne's medical school.
Find out more
Wellbeing Charter for Doctors launched
ANZCA, RANZCOG, ACEM and RACS have united for the charter that defines wellbeing and sets out the shared responsibility for supporting doctors’ wellbeing.
Find out more
ANZCA Statement on Professional Responsibility
Concerns have been raised about some fellows who may not be upholding the college's mission statement.
Find out more
New rural generalist diploma
Rural GPs in Australia will be able to access a new rural generalist anaesthesia qualification from 2023 in a collaboration between the ANZCA, the Australian College of Rural and Remote Medicine (ACRRM) and the Royal Australian College of GPs (RACGP).
Find out more
FPM concerns about MBS changes
FPM has written to Australian health officials seeking an urgent response to concerns about imminent MBS changes
Find out more
Record grant for ANZCA CTN trial
The CALIPSO trial has been awarded $A8 million by Australia's Medical Research Future Fund.
Find out more
CPD review project update - determining the CPD framework
The CPD review project group has transitioned to stage two of the project plan, to determine the updated CPD framework and meet the new regulatory requirements.
Find out more
PADDI Trial results announced
A large scale trial by Monash University has definitively found a drug commonly used during anaesthesia before surgery to prevent nausea and vomiting does not increase the risk of a surgical wound infection as once feared.
Find out more